disease areas

Antiphospholipid Syndrome (APS)

This disorder manifests clinically as venous or arterial thrombosis and/or fetal loss.

view brochure

Improving diagnostic accuracy.

To help improve the diagnosis of APS, we’ve introduced QUANTA Lite® PS/PT. This new assay is designed to increase the sensitivity in the diagnosis of APS without sacrificing specificity. It can help confirm a diagnosis even when a patient has already started anti-­coagulation treatment. When used in combination with other markers, it offers insights for risk assessment related to thrombotic events and recurring pregnancy loss.

HIGHLIGHTS
  • Improved patient care.
    Patients need not interrupt anti­coagulation therapy for an accurate diagnosis of APS.
  • Aid in clinical assessments.
    QUANTA Lite PS/PT assays deliver optimal results when used in combination with other QUANTA Lite APS tests – helping physicians diagnose APS quickly and confidently.

Reagents